Literature DB >> 10744677

Solution structure and backbone dynamics of long-[Arg(3)]insulin-like growth factor-I.

L G Laajoki1, G L Francis, J C Wallace, J A Carver, M A Keniry.   

Abstract

Long-[Arg(3)]insulin-like growth factor-I (IGF-I) is a potent analog of insulin-like growth factor-I that has been modified by a Glu(3) --> Arg mutation and a 13-amino acid extension appended to the N terminus. We have determined the solution structure of (15)N-labeled Long-[Arg(3)]-IGF-I using high resolution NMR and restrained molecular dynamics techniques to a precision of 0.82 +/- 0.28 A root mean square deviation for the backbone heavy atoms in the three alpha-helices and 3.5 +/- 0.9 A root mean square deviation for all backbone heavy atoms excluding the 8 N-terminal residues and the 8 C-terminal eight residues. Overall, the structure of the IGF-I domain is consistent with earlier studies of IGF-I with some minor changes remote from the N terminus. The major variations in the structure, compared with IGF-I, occur at the N terminus with a substantial reorientation of the N-terminal three residues of the IGF-I domain. These results are interpreted in terms of the lower binding affinity for insulin-like growth factor-binding proteins. The backbone dynamics of Long-[Arg(3)]IGF-I were investigated using (15)N nuclear spin relaxation and the heteronuclear nuclear Overhauser enhancement (NOE). There is a considerable degree of flexibility in Long-[Arg(3)]IGF-I, even in the alpha-helices, as indicated by an average ((1)H)(15)N NOE of 0.55 for the regions. The largest heteronuclear NOEs are observed in the helical regions, lower heteronuclear NOEs are observed in the C-domain loop separating helix 1 from helix 2, and negative heteronuclear NOEs are observed in the N-terminal extension and at the C terminus. Despite these data indicating conformational flexibility for the N-terminal extension, slow amide proton exchange was observed for some residues in this region, suggesting some transitory structure does exist, possibly a molten helix. A certain degree of flexibility may be necessary in all insulin-like growth factors to enable association with various receptors and binding proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744677     DOI: 10.1074/jbc.275.14.10009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.

Authors:  W Zesławski; H G Beisel; M Kamionka; W Kalus; R A Engh; R Huber; K Lang; T A Holak
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

2.  Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding.

Authors:  Michael D Glidden; Yanwu Yang; Nicholas A Smith; Nelson B Phillips; Kelley Carr; Nalinda P Wickramasinghe; Faramarz Ismail-Beigi; Michael C Lawrence; Brian J Smith; Michael A Weiss
Journal:  J Biol Chem       Date:  2017-11-07       Impact factor: 5.157

3.  Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes.

Authors:  Biruhalem Assefa; Ayman M Mahmoud; Andreas F H Pfeiffer; Andreas L Birkenfeld; Joachim Spranger; Ayman M Arafat
Journal:  Oxid Med Cell Longev       Date:  2017-12-20       Impact factor: 6.543

4.  Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain.

Authors:  Rozálie Hexnerová; Květoslava Křížková; Milan Fábry; Irena Sieglová; Kateřina Kedrová; Michaela Collinsová; Pavlína Ullrichová; Pavel Srb; Christopher Williams; Matthew P Crump; Zdeněk Tošner; Jiří Jiráček; Václav Veverka; Lenka Žáková
Journal:  J Biol Chem       Date:  2016-08-10       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.